SD

Sandesh Dattatray Deshmukh

Active Director Director DIN 11697994
DIN 11697994 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandesh Dattatray Deshmukh

Data last updated:

Sandesh Dattatray Deshmukh is a Director at Devansh Chemi Pharma Private Limited (since 2026).

DIN 11697994
Primary Designation Director
First Appointment 04 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Devansh Chemi Pharma Private Limited U46497MR2026PTC476237
Director04 May 20262026Active

Board colleagues of Sandesh Dattatray Deshmukh

NameDINCompanyDesignation
Sitaram Haribhau Gund10361094Devansh Chemi Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Devansh Chemi Pharma Private Limited
Premium access

Shareholding and investment profile for Sandesh Dattatray Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandesh Dattatray Deshmukh

Sandesh Dattatray Deshmukh currently holds 1 directorship: Devansh Chemi Pharma Private Limited (Director, since 04 May 2026).

Sandesh Dattatray Deshmukh was first appointed on 04 May 2026 as Director at Devansh Chemi Pharma Private Limited.

The current boards of Sandesh Dattatray Deshmukh's companies include Sitaram Haribhau Gund (Devansh Chemi Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available